New Non-Steroidal Topical Cream for Atopic Dermatitis

Official Title: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis

The purpose of this study is to find out the safety and the effectiveness of an investigational drug called GSK2894512 (study cream), when applied in different strengths to the skin for the treatment of Atopic Dermatitis (AD) in adolescents and adults. GSK2894512 is an investigational drug, which means that it has not been approved by the Food and Drug Administration (FDA).

NCT02564055
Paller, Amy, MD
Interventional
Yes

Contact Information:

Erin Ibler

Clinical Research Associate

312.695.0281